Study Suggests That Kidney Disease Researchers Aren’t Considering Patient-Focused Outcomes
source: pixabay.com

Study Suggests That Kidney Disease Researchers Aren’t Considering Patient-Focused Outcomes

According to a story from PR Newswire, a recent study indicated that researchers that were focused on kidney illnesses such as chronic kidney disease, congenital nephrotic syndrome, and glomerulonephritis have not been…

Continue Reading Study Suggests That Kidney Disease Researchers Aren’t Considering Patient-Focused Outcomes
Living with Hereditary Angiodema: My Life was Changed in an Instant, Part One
Source: Loukisha Olive-McCoy

Living with Hereditary Angiodema: My Life was Changed in an Instant, Part One

From birth until my mid-thirties I was a very active person. I loved dancing West Coast Swing, doing yoga, and cooking large meals for my ‘Ohana. The word "'Ohana" describes…

Continue Reading Living with Hereditary Angiodema: My Life was Changed in an Instant, Part One
A Groundbreaking Marijuana-Derived Treatment is Getting Closer to FDA Approval for Treating Rare Forms of Epilepsy
source: pixabay.com

A Groundbreaking Marijuana-Derived Treatment is Getting Closer to FDA Approval for Treating Rare Forms of Epilepsy

According to a story from statnews.com, a drug derived from substances originating in the cannabis plant may be nearing approval by the U.S. Food and Drug Administration. The drug is…

Continue Reading A Groundbreaking Marijuana-Derived Treatment is Getting Closer to FDA Approval for Treating Rare Forms of Epilepsy
Devan Demmons and Service Dog Duke Make Pageant History while Raising Awareness about Dysautonomia
source: pixabay.com

Devan Demmons and Service Dog Duke Make Pageant History while Raising Awareness about Dysautonomia

The 2018 Mrs. Maine International Pageant will be so much more than a celebration of poise and beauty. It will also make history when Devan Demmons will proudly walk on…

Continue Reading Devan Demmons and Service Dog Duke Make Pageant History while Raising Awareness about Dysautonomia
New Drug Gains Approval For Treating X-Linked Hypophosphatemia in the U.S.
source: pixabay.com

New Drug Gains Approval For Treating X-Linked Hypophosphatemia in the U.S.

According to a story from globenewswire.com, the pharmaceutical companies Ultragenyx and Kyowa Kirin recently issued an announcement that the U.S. FDA has granted approval to their new treatment Crysvita (burosumab-twza).…

Continue Reading New Drug Gains Approval For Treating X-Linked Hypophosphatemia in the U.S.